Akari Therapeutics

CEO Abizer Gaslightwala brings substantial oncology commercial experience from Jazz, Amgen, Pfizer, and J&J, and the interim CFO previously held senior finance roles at Ionis and Amgen. Governance actions stabilized listing compliance and enabled financing.

Execution risk remains high given the company’s scale, but the leadership profile is a relative strength versus peers of similar size.